Please login to the form below
anaesthetics
This page shows the latest anaesthetics news and features for those working in and with pharma, biotech and healthcare.
FDA panel backs J&J’s new-class antidepressant
The nasal spray formulation of esketamine – a derivative of the anaesthetic ketamine that has the proposed name Spravato – was backed by a 14-2 vote by an FDA advisory committee yesterday
Latest news
-
AcelRX’s potent opioid tablets set to win FDA backing for pain relief
Evaluating the safety and effectiveness of products for use in anaesthesiology and surgery, the Anaesthetic and Analgesic Drug Products Advisory Committee voted 10 to 3 in favour of the drug.
-
Heron boosted by new data for ‘breakthrough’ pain drug
Shares jumped by a third after trial announcement. Heron Pharma has new data on its combination anaesthetic drug, and a breakthrough designation from the FDA, which suggests it could have an ... Heron’s rival candidate – called HTX-011 – pairs up a
-
Iontas gets UK backing for chronic pain antibody project
to the central nervous system and are blocked by some local anaesthetics such as lidocaine.
-
It’s all about patient outcomes… right?
general anaesthetic. ... Routledge; London, UK, 2002. Snow SJ. Blessed Days of Anaesthesia: How Anaesthetics Changed the World.
-
Grünenthal buys Zomig rights as AZ slimming drive continues
This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood
More from news
Approximately 1 fully matching, plus 22 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2016
200+. Janssen / J&J (US). Piramal (IN). Asset acquisition. 5 injectable pain / anaesthetic products.
-
Deal Watch September 2016
500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva, Nimbex, Tracrium, Mivacron and Anectinein – excludes US/CA rights].
-
Deal Watch June 2016
Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
-
Pharma deals in June 2015
Neosaxitoxin, novel anaesthetic for local anaesthesia and post-op pain management. Collaboration, licence.
-
Pharma deals during March 2014
Baxter's medical products business has annual sales of over $9bn and a portfolio of intravenous solutions and nutritional therapies, drug delivery systems, premixed and other injectable drugs, inhalation anaesthetics and
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
It’s all about patient outcomes… right?
general anaesthetic. ... Routledge; London, UK, 2002. Snow SJ. Blessed Days of Anaesthesia: How Anaesthetics Changed the World.
-
"Legal highs" ruling leaves illegal labs laughing
These include the anaesthetic nitrous oxide, or laughing gas. . N2O has been used as a recreational drug since 1799, when 'laughing gas parties' were popular among the ruling classes.
-
Hayward Medical Communications
Allergic Disorders. Anaesthetics. Anti-infectives. Cancer/oncology. Cardiovascular. Central nervous system (CNS). Contraception.
-
Healthcare 2025: what the future holds for pharma
This was led by major advances in three core areas:. Health: Access to innovative medicines, surgery and anaesthetics, clean air and water.
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
-
Project Manager/ Account Manager
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Senior Medical Writer
-
Great salary and benefits
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Digital Account Director
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
Subscribe to our email news alerts
- Lighthouse Medical Commuications US appoints Lisa Druce as its new Managing Partner
- GW Pharma's cannabis-based medicine to be tested in dementia
- International Childhood Cancer Day 2019
- AZ says dropping MedImmune will help ‘streamline’ its R&D
- Merck puts prostate cancer firmly in Keytruda’s sights
- Biosimilar Herceptin helps Roche gain new Perjeta recommendation
PMHub
Just::Health Communications
Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...
Latest intelligence
- International Childhood Cancer Day 2019
- The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
- Immuno-oncology in 2019: the rapid evolution continues
- Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
- Mixing up Focus Groups
- A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...
Quick links
Infographics
